KCM
FOLD

Kodai Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Kodai Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.94M Buy
+605,110
New +$5.6M 0.2% 110

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Kodai Capital Management's FOLD Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Amicus Therapeutics (FOLD) in Q1 2025: 605,110 shares worth $4.94M. The stake represents 0.2% of the portfolio and ranks #110 among its holdings.

286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.

  • Kodai Capital Management held 605,110 shares of Amicus Therapeutics worth $4.94M as of Q1 2025.
  • Amicus Therapeutics was a new Kodai Capital Management position in Q1 2025.
  • Amicus Therapeutics made up 0.2% of Kodai Capital Management's portfolio in Q1 2025, its #110 holding.
  • 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.